245 related articles for article (PubMed ID: 18603648)
1. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
Laschke MW; Schwender C; Scheuer C; Vollmar B; Menger MD
Hum Reprod; 2008 Oct; 23(10):2308-18. PubMed ID: 18603648
[TBL] [Abstract][Full Text] [Related]
2. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
[TBL] [Abstract][Full Text] [Related]
3. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
Xu H; Lui WT; Chu CY; Ng PS; Wang CC; Rogers MS
Hum Reprod; 2009 Mar; 24(3):608-18. PubMed ID: 19088106
[TBL] [Abstract][Full Text] [Related]
5. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
7. Genistein does not affect vascularization and blood perfusion of endometriotic lesions and ovarian follicles in dorsal skinfold chambers of Syrian golden hamsters.
Laschke MW; Schwender C; Vollmar B; Menger MD
Reprod Sci; 2010 Jun; 17(6):568-77. PubMed ID: 20332165
[TBL] [Abstract][Full Text] [Related]
8. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD
Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
Park JS; Kim MH; Chang HJ; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
Int J Oncol; 2006 Nov; 29(5):1247-52. PubMed ID: 17016658
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.
Matsuzaki S; Darcha C
Hum Reprod; 2014 Aug; 29(8):1677-87. PubMed ID: 24876174
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
[TBL] [Abstract][Full Text] [Related]
12. [Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate].
Jiao ZQ; Lü XZ; Guo YC; Kan B; Xu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Sep; 41(5):380-6. PubMed ID: 18206010
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation.
Laschke MW; Elitzsch A; Scheuer C; Holstein JH; Vollmar B; Menger MD
Br J Pharmacol; 2006 Sep; 149(2):137-44. PubMed ID: 16894343
[TBL] [Abstract][Full Text] [Related]
15. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
Fu Y; Chen A
Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517
[TBL] [Abstract][Full Text] [Related]
16. Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells.
Waleh NS; Chao WR; Bensari A; Zaveri NT
Anticancer Res; 2005; 25(1A):397-402. PubMed ID: 15816564
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate from green tea negatively affects swine granulosa cell function.
Basini G; Bianco F; Grasselli F
Domest Anim Endocrinol; 2005 Apr; 28(3):243-56. PubMed ID: 15760666
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
19. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis.
Laschke MW; Elitzsch A; Scheuer C; Vollmar B; Menger MD
Fertil Steril; 2007 Jan; 87(1):163-71. PubMed ID: 17081538
[TBL] [Abstract][Full Text] [Related]
20. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
